Lpl Financial LLC Acelrx Pharmaceuticals Inc Transaction History

Lpl Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.18 - $0.29 $2,052 - $3,305	11,400 New	11,400 $3,000
Q4 2021 Feb 14, 2022	SELL	$0.49 - $1.02 $21,471 - $44,695	-43,819 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.93 - $1.51 $22,997 - $37,340	24,729 Added 129.54%	43,819 $45,000
Q2 2021 Aug 13, 2021	BUY	$1.03 - $1.7 $8,288 - $13,679	8,047 Added 72.87%	19,090 $26,000
Q1 2021 May 14, 2021	BUY	$1.25 - $2.77 $13,803 - $30,589	11,043 New	11,043 $19,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.